三联疗法联合参苓白术散治疗慢性糜烂性胃炎临床观察  

Clinical Observation of Triple Therapy Combined with Shenling Baizhu Powder in Treatment of Chronic Erosive Gastritis

作　　者：陈小龙[1] 钟荣光[1] 张洁贞[1] 徐林照[1] 

机构地区：[1]江门市新会区中医院,广东江门529100

出　　处：《新中医》2014年第2期64-66,共3页New Chinese Medicine

摘　　要：目的:观察三联疗法加参苓白术散治疗慢性糜烂性胃炎(CEG)的临床疗效。方法:选取79例CEG患者随机分为2组进行治疗。对照组39例采用三联疗法治疗,即口服克拉霉素缓释片、雷贝拉唑钠胶囊和甲硝唑片。观察组40例在对照组三联疗法的基础上加用参苓白术散治疗。比较2组临床疗效。结果:观察组临床治愈率为67.5%,总有效率为97.5%;对照组临床治愈率为35.9%,总有效率为79.5%,2组临床治愈率及总有效率比较,差异均有显著性意义(P<0.05)。结论:三联疗法联合参苓白术散治疗CEG有显著的疗效。Objective： To investigate the clinical efficacy of the triple therapy combined with Shenling Baizhu Powder for the treatment of chronic erosive gastritis（CEG）. Methods： Seventy-nine cases of CEG were selected and randomly divided into 2 groups. The control group had 39 cases and was treated by the triple therapy of oral use of clarithromycin sustained release tablets, rabeprazole m sodium capsule and metronidazole tablets. The observation group had 40 cases and was given Shenling Baizhu Powder combined with the tripte therapy. After treatment, the therapeutic effect was compared in the two groups. Results： The recovery rate of observation group was 67.5%, and the total effective rate was 97.5%, obviously superior to 35.9%, 79.5% in the control group, the difference being significant （P 〈 0.01）. Conclusion： The triple therapy combined with Shenling Baizhu Powder has significant effects in the treatment of CEG.

关 键 词：慢性糜烂性胃炎(CEG) 三联疗法 参苓白术散 

分 类 号：R573.3[医药卫生—消化系统]